| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/28/1995 | WO1995020666A3 Transgenic non-human mammals with progressive neurologic disease |
| 09/28/1995 | CA2185647A1 Branched polyoxaalkyl macromolecules, process for making them and their uses |
| 09/27/1995 | EP0673655A1 Mri contrast medium and diagnostic method |
| 09/27/1995 | CN1108956A Coupling agent for medical ultrasonic diagnostic probe and its preparation |
| 09/26/1995 | US5453505 Photostability, nonaggregating, DNA, cells, antibodies, carbohydrates |
| 09/26/1995 | US5453448 In vivo method for estimating the lipid contant of an atheromatous lesion |
| 09/26/1995 | US5453361 Method for producing biologically active human brain derived neurotrophic factor |
| 09/26/1995 | US5453264 Chelating agent, complex compound of said chelating agent and metallic atom, and diagnostic agent comprising same |
| 09/23/1995 | CA2145035A1 Polyiodinated compounds, process for preparing them and diagnostic compositions |
| 09/21/1995 | WO1995025128A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same |
| 09/21/1995 | WO1995025124A1 Methods to diagnose and treat hiv-1 infection |
| 09/21/1995 | WO1995025093A1 Acridone-derived bisintercalators as chemotherapeutic agents |
| 09/21/1995 | WO1995024930A1 Use of green porphyrins in ocular diagnosis and therapy |
| 09/21/1995 | CA2185663A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same |
| 09/21/1995 | CA2185129A1 Methods to diagnose and treat hiv-1 infection |
| 09/20/1995 | EP0672172A1 Detecting digeorge syndrome mutations |
| 09/20/1995 | EP0672130A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 09/20/1995 | EP0671955A1 Mutagenesis testing using transgenic non-human animals carrying test dna sequences |
| 09/20/1995 | EP0671946A1 Immunoreactive peptides from epstein-barr virus |
| 09/20/1995 | EP0530343B1 Water soluble, non-ionic x-ray contrasting agents and process for producing the same |
| 09/20/1995 | EP0326595B1 Peptides and antibodies that inhibit platelet adhesion |
| 09/19/1995 | US5451599 Complex salts of hematoporphyrin and of its derivatives, their synthesis, and therapeutic agent |
| 09/19/1995 | US5451576 Tumor imaging and treatment by water soluble texaphyrin metal complexes |
| 09/19/1995 | US5451393 Wet grinding a contrast agent, modifying surface and separation |
| 09/19/1995 | US5450847 Process for making doses formulation of contrast media from concentrate |
| 09/14/1995 | WO1995024473A1 Vascular endothelial growth factor 2 |
| 09/14/1995 | WO1995024378A1 Iodinated aroyloxy ketones |
| 09/14/1995 | WO1995024225A1 Polychelants |
| 09/14/1995 | WO1995024221A1 Bioactive and/or targeted dendrimer conjugates |
| 09/14/1995 | WO1995024205A1 Methods and compositions for treatment of breast cancer |
| 09/14/1995 | WO1995024189A1 Increasing fetal hemoglobin levels using carboxylic esters |
| 09/14/1995 | WO1995024184A1 Gas filled microspheres as magnetic resonance imaging contrast agents |
| 09/14/1995 | CA2414016A1 Vascular endothelial growth factor 2 |
| 09/14/1995 | CA2184912A1 Iodinated aroyloxy ketones |
| 09/14/1995 | CA2184695A1 Increasing fetal hemoglobin levels using carboxylic esters |
| 09/14/1995 | CA2181070A1 Polychelants |
| 09/13/1995 | EP0670832A1 Hepatobiliary magnetic resonance contrast agents |
| 09/13/1995 | EP0670695A1 Polymers as contrast media for magnetic resonance imaging |
| 09/13/1995 | EP0529002A4 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |
| 09/13/1995 | EP0451236B1 Process for making aqueous dispersions |
| 09/12/1995 | US5449773 Antitumor agents |
| 09/12/1995 | US5449761 Labels and medical diagnosis |
| 09/12/1995 | US5449508 Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region |
| 09/08/1995 | WO1995023862A1 Animals with targeted gene disruption |
| 09/08/1995 | WO1995023615A1 Gas-containing microcapsules useful as contrast agents for diagnostic imaging |
| 09/06/1995 | EP0670167A1 Receptor mediated endocytosis type diagnostic agents |
| 09/06/1995 | EP0670041A1 Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds |
| 09/06/1995 | EP0669979A1 C-c ckr-1, c-c chemokine receptor |
| 09/06/1995 | EP0669913A1 Detection of hypoxia |
| 09/06/1995 | EP0669823A1 Method of ultrasonic imaging of body cavities |
| 09/05/1995 | US5447711 Contrast media |
| 09/05/1995 | US5447710 Method of making nanoparticulate X-ray blood pool contrast agents using high molecular weight nonionic surfactants |
| 09/05/1995 | US5447635 Process of concentration and purification of organic compounds |
| 08/31/1995 | WO1995022995A1 X-ray contrast compositions containing cellulose derivatives |
| 08/31/1995 | WO1995022994A1 Gas-containing microparticles, agents containing them, their use in medical diagnosis by ultrasonic techniques and methods of producing said particles and agents |
| 08/31/1995 | WO1995022993A1 Method and device for the provocation of air passage narrowing and/or the induction of sputum |
| 08/31/1995 | WO1995022991A2 Block copolymers |
| 08/31/1995 | CA2184089A1 X-ray contrast compositions containing cellulose derivatives |
| 08/31/1995 | CA2183968A1 Gas-containing microparticles, agents containing them, their use in medical diagnosis by ultrasonic techniques and methods of producing said particles and agents |
| 08/31/1995 | CA2183766A1 Block copolymers |
| 08/30/1995 | EP0669400A1 Method of diagnosing cancer or precancerous state by analysis of IRF-1-specific RNA |
| 08/30/1995 | EP0669135A1 Granular preparation for mri |
| 08/30/1995 | EP0669001A1 Determination of peptide motifs on mhc molecules. |
| 08/30/1995 | EP0668767A1 Antibodies detecting stromelysin cleavage products |
| 08/30/1995 | CN1107468A Preparation of novel heterocyclic nonionic contrast medium for radiophotograph |
| 08/29/1995 | US5446145 Diagnostic imaging, detoxification, radiotherapy |
| 08/29/1995 | US5445813 Stable microbubble suspensions as enhancement agents for ultrasound echography |
| 08/29/1995 | US5445812 Angiographic adjuvant |
| 08/29/1995 | US5445811 Organ specific emulsion |
| 08/29/1995 | US5445810 Containing iodinated organic compounds |
| 08/25/1995 | CA2143261A1 Method of diagnosing cancer, precancerous state, or susceptibility to other forms of diseases by analysis of irf-1-specific rna in biopsy samples |
| 08/24/1995 | WO1995022341A1 Labelled peptide compounds |
| 08/24/1995 | DE4406474A1 Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel Gas containing microparticles, compositions comprising them, their use in ultrasound diagnostics, and to methods for producing the particles, and means |
| 08/24/1995 | DE4406465A1 Nuclear spin tomography contrast agent |
| 08/24/1995 | CA2183421A1 Labelled peptide compounds |
| 08/23/1995 | EP0667959A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE $g(b)-AMYLOID PEPTIDE |
| 08/23/1995 | EP0566601B1 Echo contrast agent |
| 08/23/1995 | EP0515458B1 Triarylmethyl radicals and the use of inert carbon free radicals in mri |
| 08/22/1995 | US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site |
| 08/22/1995 | US5443967 DNA encoding the cancer associated SCM recognition factor |
| 08/22/1995 | US5443953 Genetic engineering; diagnosis, therapy |
| 08/22/1995 | US5443825 A polypeptide sequence as anticarcinogenic agent, suppressors; cytolysis |
| 08/22/1995 | US5443816 Peptide-metal ion pharmaceutical preparation and method |
| 08/22/1995 | US5443814 X-ray contrast compositions containing iodophenoxyalkanes and cellulose derivatives |
| 08/17/1995 | WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 08/17/1995 | WO1995021866A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain |
| 08/17/1995 | WO1995021845A1 Texaphyrin metal complexes having improved functionalization |
| 08/17/1995 | WO1995021631A1 Improvements in or relating to contrast agents |
| 08/17/1995 | WO1995019186A3 Contrast media for x-ray and magnetic resonance imaging |
| 08/17/1995 | CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 08/17/1995 | CA2182960A1 Texaphyrin metal complexes having improved functionalization |
| 08/17/1995 | CA2182681A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain |
| 08/16/1995 | EP0666859A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof |
| 08/16/1995 | EP0666830A1 Method of recovering iodine from iodated organic compounds |
| 08/16/1995 | EP0666761A1 Stimulation of an antitumor t-cell response using anti-idiotypic antibodies |
| 08/16/1995 | CN1106702A B-ultrasonic quick-developing agent for examination of gastrointestinal tract |
| 08/15/1995 | US5442021 Rare earth metal complex, radical polymerizable comonomer; medical diagnosis, marking |
| 08/15/1995 | US5441746 Electromagnetic wave absorbing, surface modified magnetic particles for use in medical applications, and their method of production |
| 08/10/1995 | WO1995021251A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions |
| 08/10/1995 | WO1995020981A1 Agent for marking bodily tissues |